 |
The Journal of Neuroscience, May 9, 2007, 27(19):5115-5126; doi:10.1523/JNEUROSCI.1242-07.2007
Previous Article | Next Article 
Neurobiology of Disease
CHIP Overexpression Reduces Mutant Androgen Receptor Protein and Ameliorates Phenotypes of the Spinal and Bulbar Muscular Atrophy Transgenic Mouse Model
Hiroaki Adachi,1
Masahiro Waza,1
Keisuke Tokui,1
Masahisa Katsuno,1,2
Makoto Minamiyama,1
Fumiaki Tanaka,1
Manabu Doyu,1 and
Gen Sobue1
1Department of Neurology, Nagoya University Graduate School of Medicine, Showa-ku, Nagoya 466-8550, Japan, and 2Institute for Advanced Research, Nagoya University, Showa-ku, Nagoya 466-8550, Japan
Correspondence should be addressed to Dr. Gen Sobue, Department of Neurology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho Showa-ku, Nagoya 466-8550, Japan. Email: sobueg{at}med.nagoya-u.ac.jp
Spinal and bulbar muscular atrophy (SBMA) is an inherited motor neuron disease caused by the expansion of a polyglutamine tract within the androgen receptor (AR). The pathologic features of SBMA are motor neuron loss in the spinal cord and brainstem and diffuse nuclear accumulation and nuclear inclusions of the mutant AR in the residual motor neurons and certain visceral organs. Many components of the ubiquitin-proteasome and molecular chaperones are also sequestered in the inclusions, suggesting that they may be actively engaged in an attempt to degrade or refold the mutant AR. C terminus of Hsc70 (heat shock cognate protein 70)-interacting protein (CHIP), a U-box type E3 ubiquitin ligase, has been shown to interact with heat shock protein 90 (Hsp90) or Hsp70 and ubiquitylates unfolded proteins trapped by molecular chaperones and degrades them. Here, we demonstrate that transient overexpression of CHIP in a neuronal cell model reduces the monomeric mutant AR more effectively than it does the wild type, suggesting that the mutant AR is more sensitive to CHIP than is the wild type. High expression of CHIP in an SBMA transgenic mouse model also ameliorated motor symptoms and inhibited neuronal nuclear accumulation of the mutant AR. When CHIP was overexpressed in transgenic SBMA mice, mutant AR was also preferentially degraded over wild-type AR. These findings suggest that CHIP overexpression ameliorates SBMA phenotypes in mice by reducing nuclear-localized mutant AR via enhanced mutant AR degradation. Thus, CHIP overexpression would provide a potential therapeutic avenue for SBMA.
Key words: CHIP; polyglutamine; SBMA; transgenic mice; protein degradation; androgen receptor
Received Dec. 25, 2006;
accepted April 4, 2007.
Correspondence should be addressed to Dr. Gen Sobue, Department of Neurology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho Showa-ku, Nagoya 466-8550, Japan. Email: sobueg{at}med.nagoya-u.ac.jp
Related articles in J. Neurosci.:
- This Week in The Journal
J. Neurosci. 2007 27: i.
[Full Text]
This article has been cited by other articles:

|
 |

|
 |
 
N. Ninkina, O. Peters, S. Millership, H. Salem, H. van der Putten, and V. L. Buchman
{gamma}-Synucleinopathy: neurodegeneration associated with overexpression of the mouse protein
Hum. Mol. Genet.,
May 15, 2009;
18(10):
1779 - 1794.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Mishra, S. K. Godavarthi, M. Maheshwari, A. Goswami, and N. R. Jana
The Ubiquitin Ligase E6-AP Is Induced and Recruited to Aggresomes in Response to Proteasome Inhibition and May Be Involved in the Ubiquitination of Hsp70-bound Misfolded Proteins
J. Biol. Chem.,
April 17, 2009;
284(16):
10537 - 10545.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Pennuto, I. Palazzolo, and A. Poletti
Post-translational modifications of expanded polyglutamine proteins: impact on neurotoxicity
Hum. Mol. Genet.,
April 15, 2009;
18(R1):
R40 - R47.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Weiss and C. O. dos Santos
Chaperoning erythropoiesis
Blood,
March 5, 2009;
113(10):
2136 - 2144.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Tokui, H. Adachi, M. Waza, M. Katsuno, M. Minamiyama, H. Doi, K. Tanaka, J. Hamazaki, S. Murata, F. Tanaka, et al.
17-DMAG ameliorates polyglutamine-mediated motor neuron degeneration through well-preserved proteasome function in an SBMA model mouse
Hum. Mol. Genet.,
March 1, 2009;
18(5):
898 - 910.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Morishima, A. M. Wang, Z. Yu, W. B. Pratt, Y. Osawa, and A. P. Lieberman
CHIP deletion reveals functional redundancy of E3 ligases in promoting degradation of both signaling proteins and expanded glutamine proteins
Hum. Mol. Genet.,
December 15, 2008;
17(24):
3942 - 3952.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Tetzlaff, P. Putcha, T. F. Outeiro, A. Ivanov, O. Berezovska, B. T. Hyman, and P. J. McLean
CHIP Targets Toxic {alpha}-Synuclein Oligomers for Degradation
J. Biol. Chem.,
June 27, 2008;
283(26):
17962 - 17968.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Mishra, P. Dikshit, S. Purkayastha, J. Sharma, N. Nukina, and N. R. Jana
E6-AP Promotes Misfolded Polyglutamine Proteins for Proteasomal Degradation and Suppresses Polyglutamine Protein Aggregation and Toxicity
J. Biol. Chem.,
March 21, 2008;
283(12):
7648 - 7656.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|